The proton therapy systems market size has grown rapidly in recent years. It will grow from $1.43 billion in 2025 to $1.58 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising incidence of cancer requiring advanced radiation therapy options, increasing installation of multi-room proton therapy facilities in hospitals, early clinical validation of proton beam delivery for pediatric and critical tumor sites, expansion of oncology infrastructure and dedicated proton therapy centers, growing awareness of reduced toxicity and side effects compared to conventional radiation.
The proton therapy systems market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for image-guided and adaptive proton therapy solutions, rising adoption of compact and single-room proton therapy systems, growing treatment volumes across lung breast and gastrointestinal cancer indications, expanding access to proton therapy in emerging healthcare markets, rising investment in precision oncology and advanced radiotherapy technologies. Major trends in the forecast period include rising adoption of proton therapy for high-precision cancer treatment, increasing utilization of image-guided proton therapy with integrated ct and pet scanners, growing preference for single-room and compact proton therapy system installations, expansion of proton therapy applications across brain head and neck and prostate cancers, increasing deployment of proton therapy centers within hospitals and specialized facilities.
The rising prevalence of cancer is expected to drive the growth of the proton therapy systems market in the coming years. Cancer comprises a group of diseases characterized by abnormal cell growth that can invade and spread to other parts of the body. The growing incidence of cancer is attributed to factors such as aging populations, lifestyle changes, environmental exposures, and advancements in detection and diagnostic techniques. Proton therapy systems are widely used in cancer treatment because they enable precise targeting of tumors with high doses of radiation while limiting exposure to surrounding healthy tissue, which can reduce side effects and enhance treatment outcomes. For example, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases reached 1,958,310 in 2023, representing an increase of 3.16% from 1,898,160 cases reported in 2022. As a result, the growing prevalence of cancer is contributing to the expansion of the proton therapy systems market.
Companies operating in the proton therapy systems market are increasingly focusing on developing more compact and accessible solutions, such as self-shielded proton accelerators, to address challenges associated with facility space constraints and installation complexity. A self-shielded proton accelerator improves safety and streamlines installation by minimizing the need for extensive external shielding structures typically required in conventional proton therapy systems. For instance, in September 2024, ProTom International, a US-based medical equipment company, introduced the Radiance 330 C proton therapy system. Designed as a compact, modular fixed-beam solution, the system can be installed within or adjacent to existing linear accelerator (LINAC) vaults. It incorporates advanced pencil beam scanning technology, options for upright patient positioning, and integrated diagnostic-quality CT imaging at the treatment isocenter. The Radiance 330 C is intended to enhance the flexibility and accessibility of proton therapy by lowering facility requirements and enabling future adaptive and image-guided treatment workflows.
In June 2024, Atlantic Health System, a US-based nonprofit healthcare network, partnered with Mevion Medical Systems as part of its plan to acquire and install the MEVION S250-FIT Proton Therapy System. Through this partnership, Atlantic Health System seeks to improve the quality and accessibility of cancer treatment by leveraging advanced proton therapy technology. Mevion Medical Systems is a US-based company that specializes in the development and manufacture of proton therapy systems.
Major companies operating in the proton therapy systems market are Hitachi Ltd, Ion Beam Applications SA, Sumitomo Heavy Industries Ltd, Mevion Medical Systems, ProNova Solutions LLC, Advanced Oncotherapy plc, Optivus Proton Therapy Inc, ProTom International, P‑Cure Ltd, Mitsubishi Electric Corporation, SHI Group, Aipuqiang Shanghai Aipuqiang Particle Equipment Co Ltd, Maisheng Medical Group, Hefei Zhongke Ionic Medicine Technology Equipment Co Ltd, Elekta AB, B dot Medical Inc, HIL Applied Medical Ltd, Provision Healthcare LLC, Siemens Healthineers AG.
North America was the largest region in the proton therapy systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proton therapy systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the proton therapy systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the proton therapy systems market by increasing import and component costs for superconducting magnets, gantry structures, imaging modules, and high-precision electronic assemblies used across robotized tables, CT-integrated, and PET-integrated proton therapy platforms, resulting in higher manufacturing and capital procurement expenses for hospitals and proton therapy centers. The effects are particularly evident in North America, Europe, and Asia-Pacific regions that rely on cross-border sourcing of accelerator components and detector systems for brain, prostate, and head and neck cancer applications. These higher landed costs have contributed to extended project timelines and deferred purchasing decisions in cost-sensitive facilities; however, tariffs are also encouraging localized fabrication, regional supply-chain partnerships, and near-shoring initiatives, generating selective positive outcomes for domestic radiotherapy equipment producers.
The proton therapy systems market research report is one of a series of new reports that provides proton therapy systems market statistics, including proton therapy systems industry global market size, regional shares, competitors with a proton therapy systems market share, detailed proton therapy systems market segments, market trends and opportunities, and any further data you may need to thrive in the proton therapy systems industry. This proton therapy systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Proton therapy systems represent advanced medical equipment utilized in radiation therapy for cancer treatment. These systems are designed to deliver proton beams with pinpoint accuracy to tumor locations, thereby minimizing harm to adjacent healthy tissues. In comparison to traditional radiation therapy approaches, proton therapy offers superior treatment precision and decreased adverse effects.
The primary variants of proton therapy systems include those equipped with robotic positioning tables, integrated CT scanners, and integrated PET scanners. Proton therapy systems featuring robotic positioning tables incorporate advanced robotic technology to ensure precise patient positioning during treatment, facilitating the accurate delivery of proton beams to targeted areas. This not only enhances treatment efficacy but also improves patient comfort. These systems are available in single-room and multi-room configurations suitable for treating various types of cancer, such as brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, among others. End-users of proton therapy systems encompass hospitals, proton therapy centers, and other medical facilities.
The proton therapy systems market consists of sales of cyclotron-based proton therapy systems, synchrotron-based proton therapy systems, and passive scattering systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The proton therapy systems market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for image-guided and adaptive proton therapy solutions, rising adoption of compact and single-room proton therapy systems, growing treatment volumes across lung breast and gastrointestinal cancer indications, expanding access to proton therapy in emerging healthcare markets, rising investment in precision oncology and advanced radiotherapy technologies. Major trends in the forecast period include rising adoption of proton therapy for high-precision cancer treatment, increasing utilization of image-guided proton therapy with integrated ct and pet scanners, growing preference for single-room and compact proton therapy system installations, expansion of proton therapy applications across brain head and neck and prostate cancers, increasing deployment of proton therapy centers within hospitals and specialized facilities.
The rising prevalence of cancer is expected to drive the growth of the proton therapy systems market in the coming years. Cancer comprises a group of diseases characterized by abnormal cell growth that can invade and spread to other parts of the body. The growing incidence of cancer is attributed to factors such as aging populations, lifestyle changes, environmental exposures, and advancements in detection and diagnostic techniques. Proton therapy systems are widely used in cancer treatment because they enable precise targeting of tumors with high doses of radiation while limiting exposure to surrounding healthy tissue, which can reduce side effects and enhance treatment outcomes. For example, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases reached 1,958,310 in 2023, representing an increase of 3.16% from 1,898,160 cases reported in 2022. As a result, the growing prevalence of cancer is contributing to the expansion of the proton therapy systems market.
Companies operating in the proton therapy systems market are increasingly focusing on developing more compact and accessible solutions, such as self-shielded proton accelerators, to address challenges associated with facility space constraints and installation complexity. A self-shielded proton accelerator improves safety and streamlines installation by minimizing the need for extensive external shielding structures typically required in conventional proton therapy systems. For instance, in September 2024, ProTom International, a US-based medical equipment company, introduced the Radiance 330 C proton therapy system. Designed as a compact, modular fixed-beam solution, the system can be installed within or adjacent to existing linear accelerator (LINAC) vaults. It incorporates advanced pencil beam scanning technology, options for upright patient positioning, and integrated diagnostic-quality CT imaging at the treatment isocenter. The Radiance 330 C is intended to enhance the flexibility and accessibility of proton therapy by lowering facility requirements and enabling future adaptive and image-guided treatment workflows.
In June 2024, Atlantic Health System, a US-based nonprofit healthcare network, partnered with Mevion Medical Systems as part of its plan to acquire and install the MEVION S250-FIT Proton Therapy System. Through this partnership, Atlantic Health System seeks to improve the quality and accessibility of cancer treatment by leveraging advanced proton therapy technology. Mevion Medical Systems is a US-based company that specializes in the development and manufacture of proton therapy systems.
Major companies operating in the proton therapy systems market are Hitachi Ltd, Ion Beam Applications SA, Sumitomo Heavy Industries Ltd, Mevion Medical Systems, ProNova Solutions LLC, Advanced Oncotherapy plc, Optivus Proton Therapy Inc, ProTom International, P‑Cure Ltd, Mitsubishi Electric Corporation, SHI Group, Aipuqiang Shanghai Aipuqiang Particle Equipment Co Ltd, Maisheng Medical Group, Hefei Zhongke Ionic Medicine Technology Equipment Co Ltd, Elekta AB, B dot Medical Inc, HIL Applied Medical Ltd, Provision Healthcare LLC, Siemens Healthineers AG.
North America was the largest region in the proton therapy systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proton therapy systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the proton therapy systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the proton therapy systems market by increasing import and component costs for superconducting magnets, gantry structures, imaging modules, and high-precision electronic assemblies used across robotized tables, CT-integrated, and PET-integrated proton therapy platforms, resulting in higher manufacturing and capital procurement expenses for hospitals and proton therapy centers. The effects are particularly evident in North America, Europe, and Asia-Pacific regions that rely on cross-border sourcing of accelerator components and detector systems for brain, prostate, and head and neck cancer applications. These higher landed costs have contributed to extended project timelines and deferred purchasing decisions in cost-sensitive facilities; however, tariffs are also encouraging localized fabrication, regional supply-chain partnerships, and near-shoring initiatives, generating selective positive outcomes for domestic radiotherapy equipment producers.
The proton therapy systems market research report is one of a series of new reports that provides proton therapy systems market statistics, including proton therapy systems industry global market size, regional shares, competitors with a proton therapy systems market share, detailed proton therapy systems market segments, market trends and opportunities, and any further data you may need to thrive in the proton therapy systems industry. This proton therapy systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Proton therapy systems represent advanced medical equipment utilized in radiation therapy for cancer treatment. These systems are designed to deliver proton beams with pinpoint accuracy to tumor locations, thereby minimizing harm to adjacent healthy tissues. In comparison to traditional radiation therapy approaches, proton therapy offers superior treatment precision and decreased adverse effects.
The primary variants of proton therapy systems include those equipped with robotic positioning tables, integrated CT scanners, and integrated PET scanners. Proton therapy systems featuring robotic positioning tables incorporate advanced robotic technology to ensure precise patient positioning during treatment, facilitating the accurate delivery of proton beams to targeted areas. This not only enhances treatment efficacy but also improves patient comfort. These systems are available in single-room and multi-room configurations suitable for treating various types of cancer, such as brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, among others. End-users of proton therapy systems encompass hospitals, proton therapy centers, and other medical facilities.
The proton therapy systems market consists of sales of cyclotron-based proton therapy systems, synchrotron-based proton therapy systems, and passive scattering systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Proton Therapy Systems Market Characteristics
3. Proton Therapy Systems Market Supply Chain Analysis
4. Global Proton Therapy Systems Market Trends and Strategies
5. Proton Therapy Systems Market Analysis of End Use Industries
7. Global Proton Therapy Systems Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Proton Therapy Systems Total Addressable Market (TAM) Analysis for the Market
9. Proton Therapy Systems Market Segmentation
10. Proton Therapy Systems Market Regional and Country Analysis
11. Asia-Pacific Proton Therapy Systems Market
12. China Proton Therapy Systems Market
13. India Proton Therapy Systems Market
14. Japan Proton Therapy Systems Market
15. Australia Proton Therapy Systems Market
16. Indonesia Proton Therapy Systems Market
17. South Korea Proton Therapy Systems Market
18. Taiwan Proton Therapy Systems Market
19. South East Asia Proton Therapy Systems Market
20. Western Europe Proton Therapy Systems Market
21. UK Proton Therapy Systems Market
22. Germany Proton Therapy Systems Market
23. France Proton Therapy Systems Market
24. Italy Proton Therapy Systems Market
25. Spain Proton Therapy Systems Market
26. Eastern Europe Proton Therapy Systems Market
27. Russia Proton Therapy Systems Market
28. North America Proton Therapy Systems Market
29. USA Proton Therapy Systems Market
30. Canada Proton Therapy Systems Market
31. South America Proton Therapy Systems Market
32. Brazil Proton Therapy Systems Market
33. Middle East Proton Therapy Systems Market
34. Africa Proton Therapy Systems Market
36. Proton Therapy Systems Market Competitive Landscape and Company Profiles
37. Proton Therapy Systems Market Other Major and Innovative Companies
40. Proton Therapy Systems Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Proton Therapy Systems Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses proton therapy systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for proton therapy systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The proton therapy systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Proton Therapy Systems With Robotized Positioning Table; Proton Therapy Systems With Integrated CT Scanner; Proton Therapy Systems With Integrated PET Scanner2) By Setup Type: Single Room; Multi Room
3) By Application: Brain And Central Nervous System Cancer; Head And Neck Cancer; Prostate Cancer; Breast Cancer; Lung Cancer; Gastrointestinal Cancer; Other Applications
4) By End-User: Hospitals; Proton Therapy Center; Other End-Users
Subsegments:
1) By Proton Therapy Systems With Robotized Positioning Table: Fixed Position Robotized Table Systems; Movable Position Robotized Table Systems2) By Proton Therapy Systems With Integrated CT Scanner: Conventional CT Scanner Integrated Systems; High-Resolution CT Scanner Integrated Systems
3) By Proton Therapy Systems With Integrated PET Scanner: Low-Dose PET Scanner Integrated Systems; High-Resolution PET Scanner Integrated Systems
Companies Mentioned: Hitachi Ltd; Ion Beam Applications SA; Sumitomo Heavy Industries Ltd; Mevion Medical Systems; ProNova Solutions LLC; Advanced Oncotherapy plc; Optivus Proton Therapy Inc; ProTom International; P‑Cure Ltd; Mitsubishi Electric Corporation; SHI Group; Aipuqiang Shanghai Aipuqiang Particle Equipment Co Ltd; Maisheng Medical Group; Hefei Zhongke Ionic Medicine Technology Equipment Co Ltd; Elekta AB; B dot Medical Inc; HIL Applied Medical Ltd; Provision Healthcare LLC; Siemens Healthineers AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Proton Therapy Systems market report include:- Hitachi Ltd
- Ion Beam Applications SA
- Sumitomo Heavy Industries Ltd
- Mevion Medical Systems
- ProNova Solutions LLC
- Advanced Oncotherapy plc
- Optivus Proton Therapy Inc
- ProTom International
- P‑Cure Ltd
- Mitsubishi Electric Corporation
- SHI Group
- Aipuqiang Shanghai Aipuqiang Particle Equipment Co Ltd
- Maisheng Medical Group
- Hefei Zhongke Ionic Medicine Technology Equipment Co Ltd
- Elekta AB
- B dot Medical Inc
- HIL Applied Medical Ltd
- Provision Healthcare LLC
- Siemens Healthineers AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.58 Billion |
| Forecasted Market Value ( USD | $ 2.22 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
